Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05463263
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2022-06-30
Brief Title:
A Phase 12 Study of STP938 for Adult Subjects With RelapsedRefractory B-Cell and T-Cell Lymphomas
Sponsor:
Step Pharma SAS
Organization:
Step Pharma SAS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma T-Cell |
| Lymphoma B-Cell |
Keywords: